Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+3.44%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$70.7B
AUM Growth
+$10.3B
(+17%)
Cap. Flow
+$8.68B
Cap. Flow
% of AUM
12.27%
Top 10 Holdings %
Top 10 Hldgs %
34.21%
Holding
2,932
New
703
Increased
743
Reduced
758
Closed
533
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.16B |
| 2 |
Microsoft
MSFT
|
+$878M |
| 3 |
Amazon
AMZN
|
+$578M |
| 4 |
Apple
AAPL
|
+$531M |
| 5 |
Johnson & Johnson
JNJ
|
+$474M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$478M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$470M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$445M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$400M |
| 5 |
Micron Technology
MU
|
+$288M |
Sector Composition
| 1 | Technology | 19.84% |
| 2 | Consumer Discretionary | 14.56% |
| 3 | Healthcare | 13.07% |
| 4 | Financials | 8.25% |
| 5 | Industrials | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Protara Therapeutics
TARA
$120M
| $161K | ﹤0.01% |
+77,351
| New | +$161K |
|
2102
Babcock & Wilcox
BW
$266M
| $157K | ﹤0.01% |
+108,233
| New | +$157K |
|
2103
Leap Therapeutics
LPTX
$11.7M
| $156K | ﹤0.01% |
79,758
+58,094
| +268% | +$114K |
|
2104
Identive
INVE
$89.2M
| $153K | ﹤0.01% |
35,503
-4,206
| -11% | -$18.1K |
|
2105
Bridger Aerospace
BAER
$106M
| $150K | ﹤0.01% |
40,212
-14,098
| -26% | -$52.7K |
|
2106
Owens & Minor
OMI
$423M
| $150K | ﹤0.01% |
11,100
+3,077
| +38% | +$41.5K |
|
|
VLRS
2107
Controladora Vuela Compañía de Aviación
VLRS
$712M
| $150K | ﹤0.01% |
23,518
-3,495
| -13% | -$22.2K |
|
2108
Travelzoo
TZOO
$103M
| $149K | ﹤0.01% |
19,669
-29,847
| -60% | -$227K |
|
2109
Gold Royalty Corp
GROY
$615M
| $148K | ﹤0.01% |
+104,637
| New | +$148K |
|
2110
Global Net Lease
GNL
$1.81B
| $147K | ﹤0.01% |
+19,990
| New | +$147K |
|
2111
Standard BioTools
LAB
$489M
| $144K | ﹤0.01% |
81,617
| – | – |
|
2112
FerroAtlántica
GSM
$780M
| $144K | ﹤0.01% |
26,951
-481,922
| -95% | -$2.58M |
|
2113
SEACOR Marine Holdings
SMHI
$171M
| $143K | ﹤0.01% |
10,592
-31,505
| -75% | -$425K |
|
|
MDV
2114
Modiv Industrial
MDV
$150M
| $143K | ﹤0.01% |
+10,097
| New | +$143K |
|
2115
Cerence
CRNC
$403M
| $142K | ﹤0.01% |
50,100
-48,295
| -49% | -$137K |
|
2116
RLX Technology
RLX
$3.22B
| $142K | ﹤0.01% |
77,000
-226,560
| -75% | -$417K |
|
2117
Sera Prognostics
SERA
$117M
| $142K | ﹤0.01% |
23,922
-16,292
| -41% | -$96.4K |
|
|
EH
2118
EHang Holdings
EH
$1.13B
| $142K | ﹤0.01% |
10,420
-16,730
| -62% | -$227K |
|
|
ADAP
2119
Adaptimmune Therapeutics
ADAP
$13.5M
| $141K | ﹤0.01% |
144,880
-109,133
| -43% | -$106K |
|
2120
Vanda Pharmaceuticals
VNDA
$265M
| $138K | ﹤0.01% |
24,504
-42,141
| -63% | -$238K |
|
2121
Latham Group
SWIM
$911M
| $138K | ﹤0.01% |
45,500
| – | – |
|
|
CMRX
2122
DELISTED
Chimerix, Inc.
CMRX
| $137K | ﹤0.01% |
+156,076
| New | +$137K |
|
|
NEXN
2123
Nexxen International
NEXN
$606M
| $136K | ﹤0.01% |
+24,207
| New | +$136K |
|
2124
Corvus Pharmaceuticals
CRVS
$442M
| $136K | ﹤0.01% |
+74,559
| New | +$136K |
|
2125
Sunrun
RUN
$3.74B
| $135K | ﹤0.01% |
11,405
-1,542,040
| -99% | -$18.3M |
|